Table 1 Migraine subject characteristics
Subject | Age | Sex | Years suffering | Pain side | Aura | Migraine attack/ month | Intensity (0–5) | Migraine medications |
|---|---|---|---|---|---|---|---|---|
1 | 31 | F | 25 | R | Y | 5–8 | 3–4 | paracetamol |
2 | 24 | F | 20 | B | N | 4 | 4 | ibuprofen, paracetamol |
3 | 26 | F | 12 | R | N | 2 | 3–4 | ibuprofen |
4 | 27 | F | 12 | R | Y | 1 | 4 | ibuprofen |
5 | 23 | F | 4 | R | N | 4 | 4 | triptan |
6 | 25 | F | 12 | L | N | 5 | 3 | aspirin, rizatriptan |
7 | 21 | F | 1.5 | L | N | 4 | 3 | ibuprofen, paracetamol |
8 | 25 | F | 1 | L | N | 3 | 5 | paracetamol |
9 | 29 | F | 13 | R | N | 1 | 2.5 | ibuprofen |
10 | 26 | F | 5 | R | N | 1 | 2 | aspirin, ibuprofen, codeine |
11 | 23 | F | 6 | R | N | 1 | 3–4 | ibuprofen |
12 | 23 | F | 10 | B | N | 0.5–1 | 4 | ibuprofen, codeine |
13 | 46 | F | 15–20 | B | N | 1 | 3 | sumatriptan |
14 | 41 | F | 40 | B | N | 2 | 4 | sumatriptan |
15 | 26 | M | 15 | B | N | 8 | 3 | TCE, paracetamol, codeine |
16 | 23 | M | 3–4 | B | N | 0.5–1 | 3.5 | paracetamol, codeine |
17 | 23 | M | 4–5 | B | N | 0.5–1 | 4 | paracetamol |
18 | 55 | F | 40 | R | N | 0.5–1 | 3–4 | sumatriptan |
19 | 26 | M | 20 | R | N | 0.5–1 | 4 | metamizole |
20 | 49 | F | 30 | B | N | 0.5–1 | 5 | rizatriptan, paracetamol |
21 | 34 | F | 15 | L | Y | 2 | 3 | ibuprofen, paracetamol |
22 | 26 | F | 5 | B | Y | 1 | 3 | paracetamol |
23 | 25 | F | 7–8 | L | N | 5–8 | 3 | rizatriptan, benzoate |
24 | 27 | M | 4 | B | N | 0.5–1 | 4 | ibuprofen |
25 | 28 | F | 25 | R | Y | 0.25 | 5 | ibuprofen |
26 | 25 | M | 6 | L | N | 0.5–1 | 4 | paracetamol, codeine forte |
27 | 24 | F | 13 | R | Y | 3–4 | 5 | TCL, paracetamol, codeine |
28 | 19 | F | 4–5 | B | N | 3–4 | 3 | lexapro |
29 | 25 | M | 12 | L | N | 2 | 4 | paracetamol |
30 | 26 | F | 9 | R | Y | 1 | 3 | ibuprofen |
31 | 27 | F | 10–12 | R | N | 0.3 | 3 | – |
32 | 44 | M | 0.25 | B | Y | 1 | 5 | ibuprofen, paracetamol |